Improved Renal Outcomes in Kidney Transplant Recipients with Early Denovo DSAs on Belatacept versus Calcineurin Inhibitor-Based Immunosuppression

被引：0
|
作者：
Gattis, S. [1 ]
Agrawal, M. [2 ]
Pang, S. [2 ]
Basu, A. [1 ]
机构：
[1] Emory Healthcare, Atlanta, GA USA
[2] Emory Univ Hosp, 1364 Clifton Rd NE, Atlanta, GA 30322 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2023年 / 23卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
A194
引用
收藏
页码：S698 / S698
页数：1
相关论文
共 50 条
  • [31] Conversion from Calcineurin Inhibitor? to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial
    Budde, Klemens
    Prashar, Rohini
    Haller, Hermann
    Rial, Maria C.
    Kamar, Nassim
    Agarwal, Avinash
    de Fijter, Johan W.
    Rostaing, Lionel
    Berger, Stefan P.
    Djamali, Arjang
    Leca, Nicolae
    Allamassey, Lisa
    Gao, Sheng
    Polinsky, Martin
    Vincenti, Flavio
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (12): : 3252 - 3264
  • [32] Long-Term Outcome after Early Mammalian Target of Rapamycin Inhibitor-Based Immunosuppression in Kidney Transplant Recipients
    Liefeldt, Lutz
    Waiser, Johannes
    Bachmann, Friederike
    Budde, Klemens
    Friedersdorff, Frank
    Halleck, Fabian
    Lachmann, Nils
    Peters, Robert
    Rudolph, Birgit
    Uenlue, Sinem
    Wu, Kaiyin
    Glander, Petra
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (15)
  • [33] Long-Term Outcomes after Conversion to a Belatacept-Based Immunosuppression in Kidney Transplant Recipients
    Divard, Gillian
    Aubert, Olivier
    Debiais-Deschamp, Charlotte
    Raynaud, Marc
    Goutaudier, Valentin
    Sablik, Marta
    Sayeg, Caroline
    Legendre, Christophe
    Obert, Julie
    Anglicheau, Dany
    Lefaucheur, Carmen
    Loupy, Alexandre
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (05): : 628 - 637
  • [34] Belatacept Conversion for Calcineurin Inhibitor-Associated Thrombotic Microangiopathy in Kidney Transplant Recipients.
    Muhsin, S. A.
    Safa, K.
    Gilligan, H. M.
    Heher, E. C.
    Williams, W. W.
    Wojciechowski, D. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 691 - 691
  • [35] Comparison of Utilization and Clinical Outcomes for Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients
    Wen, X.
    Casey, M. J.
    Santos, A. H.
    Hartzema, A.
    Womer, K. L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (11) : 3202 - 3211
  • [36] Comparison of Clinical Outcomes of Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients.
    Wen, X.
    Casey, M.
    Santos, A.
    Hartzema, A.
    Womer, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 305 - 305
  • [37] CONVERSION FROM CALCINEURIN INHIBITOR-BASED TO EVEROLIMUS-BASED IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS: LONG-TERM OUTCOME
    Dayangac, Murat
    TRANSPLANT INTERNATIONAL, 2017, 30 : 363 - 363
  • [38] Conversion from a calcineurin inhibitor-based immunosuppressive regimen to everolimus in renal transplant recipients: Effect on renal function and proteinuria
    Morales, J.
    Fierro, A.
    Benavente, D.
    Zehnder, C.
    Ferrario, M.
    Contreras, L.
    Herzog, C.
    Buckel, E.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (03) : 591 - 593
  • [39] Hypomaguesemia and outcomes in renal transplant recipients with calcineurin inhibitor toxicity.
    Holzmacher, R
    Hofmann, RM
    Brazy, P
    Becker, B
    Djamali, A
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 429A - 429A
  • [40] Hypomagnesemia and outcomes in renal transplant recipients with calcineurin inhibitor toxicity.
    Holzmacher, RD
    Kendziorski, C
    Hofmann, MR
    Peter, B
    Bryan, BN
    Djamali, A
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 222 - 222
12345